Literature DB >> 26855509

Apoptosis, DAP-Kinase1 Expression and the Influences of Cytokine Milieu and Mesenchymal Stromal Cells on Ex Vivo Expansion of Umbilical Cord Blood-Derived Hematopoietic Stem Cells.

Naser Amirizadeh1, Arezoo Oodi1, Roya Mehrasa1, Mahin Nikougoftar1.   

Abstract

Expansion of umbilical cord blood-derived CD34(+) cells can potentially provide them in numbers sufficient for clinical applications in adult humans. In this study apoptosis rate of expanded cells, mRNA expression and promoter methylation status of DAPK1 were evaluated during cord blood hematopoietic stem cell (CB-HSC) ex vivo expansion using cytokines and a co-culture system with mesenchymal stromal cells (MSCs). Ex vivo cultures of CB-HSCs were performed in three culture conditions for 14 days: cytokines with MSCs feeder layer, cytokines without MSCs feeder layer and co-culture with MSCs feeder layer without cytokine. Total number of cells, CD34(+) cells and colony forming unit assay were performed during expansion. Flow cytometric analysis by propidium iodide was performed to detection of apoptosis rate in expanded cells. Methylation status of the DAPK1 gene promoter was analyzed using methylation specific PCR, and DAPK1 mRNA expression was evaluated by real time-PCR. Maximum CB-CD34(+) cells expansion was observed in day 10 of expansion. The highest apoptosis rate was observed in cytokine culture without feeder layer that showed significant difference with co-culture condition. The data showed that ex vivo expansion of CD34(+) cells in all three culture conditions after 10 days resulted in, significant increased expression of DAPK1, also a significant difference between co-culture without cytokine and two other cytokine culture was observed (p < 0.01). DAPK1gene promoter of expanded CD34(+) cells at days 5, 10 and 14 of culture remained in unmethylated form similar to fresh CD34(+) cells. Expression of DAPK1 in hematopoietic cells was increased during 10 days expansion of CD34(+) cells. Also no methylation of DAPK1 promoter was observed; otherwise it would be capable of initiating some leukemic cell progression or disruption in hematopoietic regeneration.

Entities:  

Keywords:  Apoptosis; Cord blood expansion; Hematopoietic stem cells; Mesenchymal stem cells

Year:  2015        PMID: 26855509      PMCID: PMC4733685          DOI: 10.1007/s12288-015-0545-y

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  31 in total

1.  Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.

Authors:  M Sanchez-Cespedes; M Esteller; L Wu; H Nawroz-Danish; G H Yoo; W M Koch; J Jen; J G Herman; D Sidransky
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

2.  Hematopoietic progenitor cells and cellular microenvironment: behavioral and molecular changes upon interaction.

Authors:  Wolfgang Wagner; Rainer Saffrich; Ute Wirkner; Volker Eckstein; Jonathon Blake; Alexandra Ansorge; Christian Schwager; Frederik Wein; Katrin Miesala; Wilhelm Ansorge; Anthony D Ho
Journal:  Stem Cells       Date:  2005-06-13       Impact factor: 6.277

Review 3.  Epigenetic changes in the myelodysplastic syndrome.

Authors:  Jean-Pierre Issa
Journal:  Hematol Oncol Clin North Am       Date:  2010-04       Impact factor: 3.722

Review 4.  Ex vivo expansion of hematopoietic cells from umbilical cord blood for clinical transplantation.

Authors:  P D Conrad; S G Emerson
Journal:  J Leukoc Biol       Date:  1998-08       Impact factor: 4.962

5.  The Stromal Activity of Mesenchymal Stromal Cells.

Authors:  Wolfgang Wagner; Rainer Saffrich; Anthony D Ho
Journal:  Transfus Med Hemother       Date:  2008-05-16       Impact factor: 3.747

Review 6.  Strategies to enhance umbilical cord blood stem cell engraftment in adult patients.

Authors:  Colleen Delaney; Mariusz Z Ratajczak; Mary J Laughlin
Journal:  Expert Rev Hematol       Date:  2010-06       Impact factor: 2.929

Review 7.  The epigenomics of cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

8.  Methylation of DAPK1 promoter: frequent but not an adverse prognostic factor in myelodysplastic syndrome.

Authors:  J Qian; D-M Yao; J Lin; Y-L Wang; L-X Han; W-R Xu; C-Y Wu
Journal:  Int J Lab Hematol       Date:  2009-01-02       Impact factor: 2.877

9.  Bone marrow mesenchymal stem cells from leukemia patients inhibit growth and apoptosis in serum-deprived K562 cells.

Authors:  Zhaohui Wei; Naiyao Chen; Hongxing Guo; Xueming Wang; Fangyun Xu; Qian Ren; ShiHong Lu; Bin Liu; Lei Zhang; Hui Zhao
Journal:  J Exp Clin Cancer Res       Date:  2009-11-03

10.  Stem cell traits in long-term co-culture revealed by time-lapse imaging.

Authors:  Y Song; A Bahnson; N Hall; H Yu; H Shen; D Koebler; R Houck; Y Xie; T Cheng
Journal:  Leukemia       Date:  2009-10-01       Impact factor: 11.528

View more
  1 in total

Review 1.  The Effect of Mesenchymal Stem Cell-Derived Extracellular Vesicles on Hematopoietic Stem Cells Fate.

Authors:  Hamze Timari; Karim Shamsasenjan; Aliakbar Movassaghpour; Parvin Akbarzadehlaleh; Davod Pashoutan Sarvar; Sara Aqmasheh
Journal:  Adv Pharm Bull       Date:  2017-12-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.